ScaleiQ is an AI-driven health technology company transforming how clinical research is conducted and understood.
At its core are proprietary correlation algorithms that uncover hidden patterns across digital and retinal biomarkers, advanced analytics, and real-world data—patterns that conventional methods often miss.
The result is a unified, longitudinal view of patient health, enabling earlier detection of safety signals, more precise monitoring of systemic toxicity, and deeper insight into disease progression and treatment response. By linking clinical trial data with real-world evidence, ScaleiQ moves beyond static snapshots to deliver continuous, data-driven insights.